Advertisement

Cell Markers in Bladder Cancer

  • N. Javadpour
Part of the Ettore Majorana International Science Series book series (EMISS, volume 8)

Abstract

Perhaps the most encouraging progress in cancer immunology has been in the field of immunodiagnosis; mainly, development of specific and sensitive immunocytochemical techniques to measure and localize tumor markers in the sera and cancer cells of cancer patients. In this chapter, we will discuss the developments and utilization of tumor markers in bladder cancer with emphasis on more clinically established and useful markers[1-19]. Nonspecific serum markers such as lactic dehydragenase, polyamines and a number of oncofetoproteins are under study[14].

Keywords

Bladder Cancer Blood Group Bladder Tumor Transitional Cell Carcinoma Cell Surface Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    S. Bergman and N. Javadpour, The cell surface antigen ABO(H) as an indicator of malignant potential in Stage A bladder carcinoma, Preliminary report, J.Urol., 119: 49 (1978).Google Scholar
  2. 2.
    J. S. Coon and R. Weinstein, Variability in the expression of the O(H) antigen in human transitional epithelium, J.Urol., 125: 301 (1981).Google Scholar
  3. 3.
    J. S. Coon and R. S. Weinstein, Detection of the ABH tissue isoantigen by immunoperoxidase methods in normal and neoplastic urethelium, Am.J.Clin.Path., 76: 163 (1981).Google Scholar
  4. 4.
    I. Davidsohn, Early immunologic diagnosis and prognosis of carcinoma, Am.J.Clin.Path., 57: 715 (1972).Google Scholar
  5. 5.
    B. A. Diamond, E. Dale, B. A. Yelton, and M. D. Scharff, Mono clonal antibodies - a new technology for producing serologic reagents, N.Engl.J.Med., 304: 1344 (1981).CrossRefGoogle Scholar
  6. 6.
    R. C. Emmott, N. Javadpour, S. M. Bergman, and T. Soares, Corre lation of the cell surface antigens with stage and grade in cancer of the bladder, J.Urol., 121: 37 (1979).Google Scholar
  7. 7.
    C. Emmott, M. Droller, and N. Javadpour, Studies of ABO(H) cell surface antigen specificity: Carcinoma in situ and nonmalig- nant lesions of the bladder, J.Urol., 125: 32–35 (1981).Google Scholar
  8. 8.
    D. R. Howard and J. G. Batsakis, Cytostructural localization of a tumor associated antigen, Science, 210: 201 (1980).ADSCrossRefGoogle Scholar
  9. 9.
    N. Javadpour, The role of radioimmunodetection in urologic cancer (in press).Google Scholar
  10. 10.
    N. Javadpour, Cell surface antigen in bladder cancer, J.Urol., March (1983).Google Scholar
  11. 11.
    F. A. Klein, M. R. Melamed, W. F. Whitmore, H. W. Herr, and P. C. Sogani, Characterization of bladder papilloma by 2 parameters DNA/RNA flow cytometry: Proceeding of 1982 AMA Abstract 73.Google Scholar
  12. 12.
    F. A. Klein, H. W. Herr, W. F. Whitmore, and M. R. Melamed, Flow cytometry in follow-up of patients with low stage bladder tumors, Proceedings of 1981 AMA Abstract 548.Google Scholar
  13. 13.
    P. H. Lange, C. Limas, and E. E. Fraley, Tissue blood group antigens and prognosis in low stage transitional cell carcinoma of the bladder, J.Urol., 119: 52 (1978).Google Scholar
  14. 14.
    M. Lippert and N. Javadpour, Cell surface antigen in renal pelvic tumors, Urology (in press).Google Scholar
  15. 15.
    P. H. Lange, C. Limas, and E. E. Fraley, Tissue blood group antigens and prognosis in low stage transitional cell carcinoma of the bladder, J.Urol., 119: 52 (1978).Google Scholar
  16. 16.
    P. H. Lange, C. Limas, and E. E. Fraley, Tissue blood group antigens and prognosis in low stage transitional cell carcinoma of the bladder, J.Urol., 119: 52 (1978).Google Scholar
  17. 17.
    C. Milstein, K. Adetugbo, N. J. Cowan, et al., Somatic cell genetics of antibody-secreting cells: Cold Spring Harbor Symp. Quant.Biol., 41: 793–803 (1977).CrossRefGoogle Scholar
  18. 18.
    B. S. Stein and A. R. Kendall, Specific red cell adherence testing and radiotherapy, Cancer, 50: 23–29 (1982).Google Scholar
  19. 19.
    J. Vafier, N. Javadpour, G. F. Worsham, and K. O’Connell, A double blind comparison of T-antigen and ABO(H) cell surface antigen in bladder cancer, Urology, (in press).Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • N. Javadpour
    • 1
  1. 1.The Surgery Branch, National Cancer InstituteNational Institute of HealthBethesdaUSA

Personalised recommendations